From: The impact of COVID-19 pandemic on cardiac surgery in Israel
2019 Group N = 173 | 2020 Group N = 108 | p-value | |
---|---|---|---|
AVR (%) | 45 (26.0) | 24 (22.2) | 0.565 |
MVR/MVr (%) | 31 (17.9) | 25 (23.1) | 0.361 |
TVr (%) | 13 (7.5) | 4 (3.7) | 0.295 |
Ascending aorta repair (%) | 17 (9.8) | 6 (5.6) | 0.295 |
Dissection repair (%) | 4 (2.3) | 2 (1.9) | 1.000 |
MAZE procedure (%) | 4 (2.3) | 6 (5.6) | 0.273 |
CABG (%) | 87 (50.3) | 54 (50.0) | 1.000 |
Number of total grafts (%) | 0.217 | ||
1 | 18 (24.0) | 8 (15.4) | |
2 | 29 (38.7) | 15 (28.8) | |
3 | 21 (28.0) | 23 (44.2) | |
4 | 7 (9.3) | 6 (11.5) | |
Cross clamp time, minutes (%) | 68.4 (30.5) | 107.4 (87.6) | 0.005 |